Genetic Technologies Reports Q1 FY22 Results

Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter ...

Related Keywords

Australia ,Melbourne ,Victoria ,United States ,United Kingdom ,Australian ,American ,Biobank Gafni ,Simon Morriss ,Predictive Panel Risk Test ,Institute Of Public Health In St Louis ,Company Multi ,Genetic Technologies Limited ,Nasdaq ,Technologies Limited ,Breast Cancer ,Colorectal Cancer ,Prostate Cancer ,Ovarian Cancer ,Coronary Artery Disease ,African American ,Public Health ,Genetic Technologies ,Australian Stock Exchange Gtg Ax ,Genetic Technologies Ltd ,